Journal article

The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy

Andy K Hsu, Hang Quach, Tsin Tai, H Miles Prince, Simon J Harrison, Joseph A Trapani, Mark J Smyth, Paul Neeson, David S Ritchie

Blood | AMER SOC HEMATOLOGY | Published : 2011

Grants

Awarded by National Health and Medical Research Council (NHMRC) of Australia


Funding Acknowledgements

This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, Program Grant no. 454569, and the Peter MacCallum Cancer Center Morris Family Grant. This study was also supported (in part) by research funding from Celgene Corp. to H.Q. M.J.S. was supported by a NHMRC Senior Principal Research Fellowship and the NHMRC Australian Fellowship. J.A.T. was supported by NHMRC Senior Principal Research Fellowships. H.Q. was supported by the Vincent Fairfax Scholarship from the Royal College of Australian Physicians.